Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants

Methylthioninium chloride (MTC) is a standard treatment for methaemoglobinaemia. A preparation of reduced MTC has been reported to increase blood oxygen saturation (SpO(2)) and lower respiratory rates in patients with severe COVID-19. We have developed a stable form of reduced methylthionine (hydrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Arastoo, Mohammad, Mazanetz, Michael P., Miller, Sonya, Shiells, Helen, Hull, Claire, Robinson, Keith, Storey, John M. D., Harrington, Charles R., Wischik, Claude M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531415/
https://www.ncbi.nlm.nih.gov/pubmed/37762050
http://dx.doi.org/10.3390/ijms241813747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531415/
https://www.ncbi.nlm.nih.gov/pubmed/37762050
http://dx.doi.org/10.3390/ijms241813747

Ejemplares similares